Приказ основних података о документу

dc.creatorLefaucheur, Jean-Pascal
dc.creatorAndre-Obadia, Nathalie
dc.creatorAntal, Andrea
dc.creatorAyache, Samar S.
dc.creatorBaeken, Chris
dc.creatorBenninger, David H.
dc.creatorCantello, Roberto M.
dc.creatorCincotta, Massimo
dc.creatorde Carvalho, Mamede
dc.creatorDe Ridder, Dirk
dc.creatorDevanne, Herve
dc.creatorDi Lazzaro, Vincenzo
dc.creatorFilipović, Saša
dc.creatorHummel, Friedhelm C.
dc.creatorJaaskelainen, Satu K.
dc.creatorKimiskidis, Vasilios K.
dc.creatorKoch, Giacomo
dc.creatorLangguth, Berthold
dc.creatorNyffeler, Thomas
dc.creatorOliviero, Antonio
dc.creatorPadberg, Frank
dc.creatorPoulet, Emmanuel
dc.creatorRossi, Simone
dc.creatorRossini, Paolo Maria
dc.creatorRothwell, John C.
dc.creatorSchonfeldt-Lecuona, Carlos
dc.creatorSiebner, Hartwig R.
dc.creatorSlotema, Christina W.
dc.creatorStagg, Charlotte J.
dc.creatorValls-Sole, Josep
dc.creatorZiemann, Ulf
dc.creatorPaulus, Walter
dc.creatorGarcia-Larrea, Luis
dc.date.accessioned2021-04-20T12:38:16Z
dc.date.available2021-04-20T12:38:16Z
dc.date.issued2014
dc.identifier.issn1388-2457
dc.identifier.urihttp://rimi.imi.bg.ac.rs/handle/123456789/555
dc.description.abstractA group of European experts was commissioned to establish guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until March 2014, regarding pain, movement disorders, stroke, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, consciousness disorders, tinnitus, depression, anxiety disorders, obsessive-compulsive disorder, schizophrenia, craving/addiction, and conversion. Despite unavoidable inhomogeneities, there is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain and the antidepressant effect of HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC). A Level B recommendation (probable efficacy) is proposed for the antidepressant effect of low-frequency (LF) rTMS of the right DLPFC, HF-rTMS of the left DLPFC for the negative symptoms of schizophrenia, and LF-rTMS of contralesional M1 in chronic motor stroke. The effects of rTMS in a number of indications reach level C (possible efficacy), including LF-rTMS of the left temporoparietal cortex in tinnitus and auditory hallucinations. It remains to determine how to optimize rTMS protocols and techniques to give them relevance in routine clinical practice. In addition, professionals carrying out rTMS protocols should undergo rigorous training to ensure the quality of the technical realization, guarantee the proper care of patients, and maximize the chances of success. Under these conditions, the therapeutic use of rTMS should be able to develop in the coming years.en
dc.publisherElsevier Ireland Ltd, Clare
dc.relationEBNeuro S.p.A, Florence, Italy
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175012/RS//
dc.relationFundacio Marato TV3 [PI110930]
dc.relationLundbeck FoundationLundbeckfonden [R59-2010-5399] Funding Source: researchfish
dc.rightsrestrictedAccess
dc.sourceClinical Neurophysiology
dc.subjectCortexen
dc.subjectIndicationen
dc.subjectNeurological diseaseen
dc.subjectNeuromodulationen
dc.subjectNoninvasive brain stimulationen
dc.subjectPsychiatric diseaseen
dc.subjectTMSen
dc.subjectTreatmenten
dc.titleEvidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)en
dc.typearticle
dc.rights.licenseARR
dc.citation.epage2206
dc.citation.issue11
dc.citation.other125(11): 2150-2206
dc.citation.rankM22
dc.citation.spage2150
dc.citation.volume125
dc.identifier.doi10.1016/j.clinph.2014.05.021
dc.identifier.pmid25034472
dc.identifier.scopus2-s2.0-84927691583
dc.identifier.wos000345519600005
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу